Establishing End-To-End Control Of Product Labeling White Paper
In heavily regulated industries including medical device manufacture, pharmaceuticals, chemicals and cosmetics, demand is intensifying for accurate, compliant and contextually-relevant labeling and customer-facing materials. Labeling has become a board-level topic now, given its strategic importance in reducing barriers to entry into new markets.
In this white paper we set out five important drivers for building a global labeling strategy over the year ahead.
Quote from White Paper: "From greater reliance on contract manufacturing, to growing use of business process outsourcing, many industries are seeing increased reliance on external partners to look after large elements of what they do. Whether someone else is making or packaging products, or looking after regulatory submissions activity, any disconnect with or blind spot between operations could prove a weak link and source of risk."